Literature DB >> 19165443

[Palliative sedation in pediatric oncology].

Julia Kovacs1, Nazar Casey, Dietmar Weixler.   

Abstract

Severe pain caused by multiple metastases in bones in a pediatric patient suffering from rhabdomyosarcoma, a solid tumor of childhood, made palliative sedation therapy after developing metastases in lung necessary. The premises for this therapy, the difference in the choice of drugs compared to adults and psychology of the dying child are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 19165443     DOI: 10.1007/s10354-008-0617-9

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  7 in total

1.  [Palliative sedation--an alternative to euthanasia in intractable pain at the end of life?].

Authors:  Martin Weber; Imke Strohscheer; Hellmut Samonigg; Christoph Huber
Journal:  Med Klin (Munich)       Date:  2005-05-13

2.  [Symptom control and ethics in final stages of COPD].

Authors:  Bernadette Hörfarter; Dietmar Weixler
Journal:  Wien Med Wochenschr       Date:  2006-05

3.  [Definitions and recommendations for palliative sedation].

Authors:  H C Müller-Busch; L Radbruch; F Strasser; R Voltz
Journal:  Dtsch Med Wochenschr       Date:  2006-12-01       Impact factor: 0.628

4.  When nothing helps: propofol as sedative and antiemetic in palliative cancer care.

Authors:  Staffan Lundström; Ulla Zachrisson; Carl Johan Fürst
Journal:  J Pain Symptom Manage       Date:  2005-12       Impact factor: 3.612

Review 5.  Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards.

Authors:  Alexander de Graeff; Mervyn Dean
Journal:  J Palliat Med       Date:  2007-02       Impact factor: 2.947

6.  Emotional burden of nurses in palliative sedation therapy.

Authors:  Tatsuya Morita; Mitsunori Miyashita; Rieko Kimura; Isamu Adachi; Yasuo Shima
Journal:  Palliat Med       Date:  2004-09       Impact factor: 4.762

7.  Correlation of the dose of midazolam for symptom control with administration periods: the possibility of tolerance.

Authors:  Tatsuya Morita; You Tei; Satoshi Inoue
Journal:  J Pain Symptom Manage       Date:  2003-04       Impact factor: 3.612

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.